What is Georgetown Dermatology?
Georgetown Dermatology operates as a premier medical practice dedicated to the comprehensive treatment of skin, hair, and nail disorders. Beyond clinical pathology, the organization has carved out a significant market share in aesthetic enhancement and restoration services. The practice is anchored by a team of double board-certified dermatologists and dermatopathologists, whose expertise has earned them recognition as Top Doctors by Washingtonian Magazine. By maintaining a broad insurance acceptance policy, including Medicare and Blue Cross Blue Shield, the firm ensures a sustainable and accessible patient base, effectively bridging the gap between specialized medical intervention and elective cosmetic procedures.
How much funding has Georgetown Dermatology raised?
Georgetown Dermatology has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Georgetown Dermatology
PPP
Public-Private Partnership
What's next for Georgetown Dermatology?
With the recent infusion of capital, Georgetown Dermatology is poised to scale its clinical infrastructure and potentially expand its service offerings. The strategic focus will likely center on integrating advanced dermatological technologies and increasing patient throughput to meet the rising demand for both medical and aesthetic skin health solutions. As the practice matures, the management team is expected to prioritize operational efficiency and the recruitment of additional top-tier specialists to maintain their reputation for clinical excellence. This late-stage financing provides the necessary runway to solidify their market leadership in the Washington D.C. metropolitan area and beyond.
See full Georgetown Dermatology company page
